US Broker Ratings

Neurogene Inc. (NGNE) Stock Analysis: Unveiling a 159.68% Potential Upside in the Biotech Sector

Neurogene Inc. (NASDAQ: NGNE) is capturing the attention of investors with a compelling potential upside of 159.68%. As a clinical-stage biotechnology company, Neurogene is at the forefront of developing genetic..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 148.87% Potential Upside in Biotech

In the dynamic world of biotechnology, CytomX Therapeutics, Inc. (NASDAQ: CTMX) emerges as a noteworthy player with its innovative approach to cancer treatment. Operating at the forefront of biopharmaceutical developments,..

Arcturus Therapeutics Holdings (ARCT) Investor Outlook: Exploring a Potential 381% Upside in the Biotech Sector

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out in the biotechnology industry with its innovative approach to developing vaccines and therapeutics for infectious diseases and rare liver and respiratory conditions...

Pacific Biosciences of California (PACB) Stock Analysis: Exploring a 68% Upside Potential

Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands at a significant crossroads in the healthcare sector, offering investors a unique opportunity to engage with a company that specializes in advanced..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Navigating a Promising Biotech Frontier with Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stands at a compelling juncture within the biotech sector, showcasing potential opportunities amidst its ongoing clinical developments. With a market cap of approximately $386.49 million,..

XOMA Royalty Corporation (XOMA) Stock Analysis: Unlocking a Potential 135% Upside in the Biotech Sector

For investors with a keen interest in the biotechnology sector, XOMA Royalty Corporation (XOMA) presents an intriguing opportunity, bolstered by a remarkable potential upside of 135.58%. This California-based company operates..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring the 66.67% Upside Potential

Nano-X Imaging Ltd (NASDAQ: NNOX) is an intriguing player in the healthcare sector, specializing in revolutionary medical devices. Headquartered in Petah Tikva, Israel, the company has positioned itself as an..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: A Biotech Gem with a 233% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) is making waves in the biotechnology sector with its innovative approach to gene and cell therapies aimed at treating life-threatening diseases. As a clinical-stage biopharmaceutical..

National Research Corporation (NRC) Stock Analysis: Navigating Through Volatility with a Strong Dividend Yield

National Research Corporation (NRC) stands as a prominent player in the healthcare sector, specializing in health information services. Headquartered in Lincoln, Nebraska, NRC has carved a niche for itself by..

Checkpoint Therapeutics, Inc. (CKPT) Valuation Insights: Exploring a 4.46% Potential Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT), a key player in the biotechnology sector with a focus on immunotherapy and targeted oncology, presents an intriguing proposition for investors. With a market capitalization..

Absci Corporation (ABSI) Stock Analysis: Exploring a 230% Potential Upside in the Growing AI-Driven Biotech Arena

Absci Corporation (NASDAQ: ABSI) is making waves in the biotechnology sector with its innovative use of artificial intelligence (AI) to revolutionize drug creation. Headquartered in Vancouver, Washington, this data-first company..

Benitec Biopharma Inc. (BNTC) Investor Outlook: A 95% Upside Potential in Biotech Innovation

Investors eyeing the biotechnology sector for promising opportunities may find Benitec Biopharma Inc. (NASDAQ: BNTC) particularly intriguing. This U.S.-based clinical-stage biotech company, with a market cap of $345.46 million, is..

Senseonics Holdings, Inc. (SENS) Stock Analysis: A Medical Device Innovator with 209% Upside Potential

Senseonics Holdings, Inc. (NASDAQ: SENS) is gaining attention in the healthcare sector, specifically within the medical devices industry, as it pushes boundaries with its innovative continuous glucose monitoring (CGM) systems...

Alpha Teknova, Inc. (TKNO) Stock Analysis: Exploring a 111.95% Potential Upside

Alpha Teknova, Inc. (TKNO) has captured the attention of investors with a compelling potential upside of 111.95%, according to analyst target prices. Operating within the healthcare sector, Alpha Teknova specializes..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a 314% Upside Potential in Precision Oncology

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its ambitious pursuit to develop therapies targeting RAS/MAPK pathway-driven cancers. With a current market cap..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: A Biotech Player with 81% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL), a notable name in the biotechnology sector, is making waves with its promising therapies aimed at improving the lives of patients dealing with hematologic disorders..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unpacking a 19% Potential Upside for Savvy Investors

The Pennant Group, Inc. (NASDAQ: PNTG), a prominent player in the healthcare sector, has drawn the attention of investors with its promising growth metrics and solid analyst ratings. As it..

Establishment Labs Holdings Inc (ESTA): Investor Outlook Reveals 44.89% Upside Potential Amidst Analyst Confidence

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is gaining attention in the medical devices sector, primarily for its innovative approach in the aesthetic and reconstructive plastic surgery market. Headquartered in Alajuela,..

BioLife Solutions, Inc. (BLFS): Analyst Ratings and a 46% Potential Upside Make This Stock a Hot Topic

BioLife Solutions, Inc. (NASDAQ: BLFS) is capturing the attention of investors with its promising position within the healthcare sector, specifically in the niche of medical instruments and supplies. The company,..

Opko Health, Inc. (OPK) Stock Analysis: A Look at the 214% Potential Upside and Analyst Ratings

Opko Health, Inc. (OPK) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in Miami, Florida, and with operations extending across the United..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds